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Abstract 
 
Despite the multidisciplinary dimension of the researches conducted under the umbrella 
synthetic biology, the founders of this new research area in the United States adopted a 
disciplinary profile to shape its institutional identity. In so doing they took inspiration from 
two already established fields with very different disciplinary patterns. The analogy with 
synthetic chemistry suggested by the term ‘synthetic biology’ is not the unique model. 
Information technology is clearly another source of inspiration. The purpose of the paper 
focused on the US context is to emphasize the diversity of views and agendas coexisting 
under the disciplinary label synthetic biology, as the two models analysed are only presented 
as two extreme postures in the community. The paper discusses the question: in which 
directions the two models shape this emerging field? Do they chart two divergent futures for 
synthetic biology?  
 
Keywords: engineering, synthetic chemistry, synthetic strategies, open source, 
biobricks, epistemic pluralism. 
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Introduction 
 
All practitioners of synthetic biology agree that this emerging field combines 
knowledge from a large number of disciplines, including molecular biology, engineering, 
mathematics, chemistry, and physics. Synthetic DNA, xeno-DNA, minimal genomes, and 
protocells could arguably be presented as exemplars of the current movement of Converging 
Technologies prompted by the nanotechnology wave. Yet they belong to a special branch of 
biology often coupled with systems biology.1 Despite its multidisciplinary dimension, 
synthetic biology follows the traditional model of academic disciplines. 
In their effort to build a community of practitioners and stabilize the emerging field, the 
pioneers of synthetic biology have looked for analogies with well-recognized fields, in order 
to establish synthetic biology as a legitimate discipline. They shape a disciplinary identity of 
their research field by using quite different models such as chemistry and information 
technology.  
The name itself  ‘Synthetic Biology’ became an official label on the occasion of the 
Synthetic Biology 1.0 Conference organized in June 2004, at MIT by Drew Endy and Tom 
Knight, both members of the department of Biology and Biological Engineering of this 
Institute. The phrase “synthetic biology” (biologie synthétique) had been introduced a long 
time ago, in 1912, by a French physico-chemist Stéphane Leduc. (Leduc 1910 and 1912) 
However it seems that this antecedent did not play any role in the choice made in 2004. There 
is no historical link between the early 20th-century attempts at engineering life-like systems 
and the new branch of biology emerging in the early 21st century. Leduc and other engineers 
of living systems such as Jacques Loeb are rediscovered but it would be counterfactual to 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 See the journal Systems and Synthetic Biology created in 2007. http://www.springer.com/biomed/journal/11693 
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present them as the ancestors of today’s synthetic biology. (Fox Keller, 2002, Bensaude-
Vincent, 2009). 
So where does this word come from? The analogy with the field of synthetic chemistry, 
which emerged in the mid-nineteenth century is quite obvious. To what extent synthetic 
chemistry can be seen as a disciplinary model for synthetic biology? If this model turns out to 
be in competition with rival models does it preclude the unity of the emerging discipline of 
synthetic biology?  
Beginning with a brief report on how the term “synthetic biology” came into use, this 
paper will survey the discourses of emergence and point to a competition between two 
models. Finally it will discuss the significance of these rival models for the further 
developments of synthetic biology.  
Before trying to describe the on-going process of discipline building in the synthetic 
biology community a few words about why this identity work matters may clarify the aims 
and perspective of this paper. From the large literature about discipline building (Gingras, 
1991; Nye, 2002; Molyneux-Hodgson and Meyer, 2009), one can retain that it is a three-fold 
process: A research field first nucleates around individual trajectories; then it is stabilized 
through a number of “community making devices” such as annual conferences, journals, 
learned societies, chairs and academic curricula, textbooks; along the process of institutional 
establishment the emerging community shapes its social identity through the views developed 
by practitioners in their public presentations about novelty, references to the past and visions 
of the future.  
This paper will focus on the views developed by synthetic biologists about novelty, 
their visions of the past and of the future rather than on their actual practices or institutional 
strategies, which are more relevant for a sociological analysis of discipline building. This 
paper rather seeks to characterize the epistemic choices of discipline builders, and to 
	   4	  
emphasize the role of their discourses about the past and the future. Such discourses are not 
just a sort of ideological wrapping or external façade isolated from epistemic choices. They 
are integral parts of the process of discipline building, which is heavily loaded with values 
and visions. Such discourses are crucial for stabilizing the social and cultural identity of a 
discipline, and they are shaped by the local contexts as much as by the objects and 
instruments of investigation. This is one reason why this case study is limited to the US 
context.2  
The social discourses of identity have two major functions. First they serve a purpose of 
legitimation. There is no historical necessity for the emergence of a discipline. In particular, 
synthetic biology is not the “natural outcome” of molecular biology and a range of alternative 
pathways could have been chosen for the establishment of the various research programs 
gathered under the umbrella ‘synthetic biology’. Many candidate disciplines or sub-
disciplines vanish or merge in already established communities in the course of the discipline-
building process. One major function of the social identity discourses is precisely to avoid 
such failures by forging a kind of historical necessity in order to establish and legitimize the 
field.  
Second, the identity work is useful to attract funds and enrol scientists because they 
shape a vision of the future, an ideal type? This is why the models chosen for building a new 
discipline matter. They provide a sort of “paradigm”. But what happens when the 
practitioners of an emerging discipline promote various disciplinary models? Can a discipline 
be built on the basis of epistemic pluralism? (Chang, 2011) 
 
1. 2000- A puzzling coinage 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	  International comparisons could help refining our understanding of the role of such discourses in discipline 
building.	  According to Molyneux-Hodgson and Meyer, 2009, the process of community building in the United 
Kingdom does not mobilize such disciplinary models. Rather it seems to be based on a science policy effort to i) 
catch up with the United States (with the not-lagging-behind argument); ii) building a network of existing 
communities and; iii) creating a sense of global collective. 
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Naming is a crucial step in discipline building, for demarcation purpose and for 
achieving visibility. (Powell, O’Malley, Müller-Wille, Calvert and Dupré, 2007) According to 
Luis Campos’s inquiry on the coinage of synthetic biology’, this phrase won over two rival 
candidate labels: ‘constructive biology’ and ‘intentional biology’. (Campos, 2009) All three 
words emphasize the introduction of design in biology, albeit with quite different 
connotations.  
‘Constructive biology’ was meant to emphasize the contrast with traditional biology, 
viewed as essentially observational and descriptive. The phrase came out as early as 1999 to 
refer to bio-inspired robotics and it seems to be mainly used by biologists working close to the 
Artificial Intelligence (AI) community: “Constructive biology (as opposed to descriptive 
biology) means understanding biological mechanisms through building systems that exhibit 
life-like properties. Applications include learning engineering tricks from biological systems, 
as well as the validation in biological modelling”. (Nahaniv et al. , 1999) AI biologists share a 
number of concerns and practices with synthetic biologists. Yet the robotics community is 
quite distinct from the circle of researchers who promoted synthetic biology as a discipline. 
Only those synthetic biologists who are engineering minimal cells, with the expectation to 
explore the origins of life or the source of individuality do occasionally use the phrase 
‘constructive biology’.3 
The alternative ‘intentional biology’ was a more serious candidate, since it had been the 
founders of the discipline - Robert Carlson, Roger Brent and Drew Endy – had used this 
phrase as early as 2000. The adjective ‘intentional’ was meant to emphasize the predictive 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 For instance George Church a professor at Harvard Medical School who is involved in a number of synthetic 
biology projects, used the term “constructive biology” to state his personal commitment: “The biggest questions 
I'm asking myself, at least in the laboratory, are: "What is it that makes us individuals?" That’s what we call the 
personal genome project. Its aim is holistic, in contrast to the usual single disease or tissue. The second is: how 
do we engineer biology? which can be called our "constructive biology" or "biological design" efforts. The two 
might intersect quite nicely in the form of personalized medicine”.       
http://blogs.nature.com/ng/freeassociation/2006/07/george_church_on_constructive.html 
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power acquired by biology thanks to the introduction of methods borrowed from engineering, 
as Carlson clearly stated: 
“When we can successfully predict the behavior of designed biological systems, then an 
intentional biology will exist. With an explicit engineering component intentional 
biology is the opposite of the current, very nearly random applications of biology as 
technology”. (Carlson, 2001, 1) 
However, when the phrase ‘intentional biology’ was publicised in the meeting “After 
Genome 6. Achieving an Intentional Biology” organized by Carlson in Tucson, Dec 2000, it 
raised intense criticisms from the biologists attending the meeting. It was perceived as a tacit 
criticism of current biotechnology as it had developed rather randomly since the 1970s.. 
(Campos, 2009, p. 18). Thus “the word ‘intentional biology’ went over like a lead balloon” 
reported Endy, who never fully endorsed the phrase ‘synthetic biology’. Even after its general 
acceptance in 2004 at the SB 1.0 Conference, he preferred to use  “engineering biology” in his 
foundational paper. (Endy, 2005)  
According to Campos, the alternative label ‘synthetic biology’ was suggested in 2001, 
by Carlos Bustamante, a biologist at Berkeley, where Carlson was a research fellow in the 
Molecular Sciences Institute until 2002.4 Strikingly Bustamante has developed a distinct 
approach, typical of bionanotechnology rather than of mainstream synthetic biology. His 
group is involved in single-molecule manipulation and detection with optical tweezers and 
single-molecule fluorescence microscopy. They investigate the behaviour of biomolecular 
motors, molecular mechanisms of control of transcription in prokaryotes. For this purpose 
they make extensive use of Scanning Force Microscopy (SFM), a technique emblematic of 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 The mission of this Institute retains the predictive turn of Carlson’s Intentional Biology: “to predict the 
behavior of cells and organisms in response to defined genetic and environmental changes. For instance, its 
Alpha project (2001-2009) aims at “predicting the quantitative behavior of a eukaryotic regulatory network in 
individual cells in response to perturbations”.  
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nanotechnology. Bustamante’s laboratory is not even mentioned among the Synthetic biology 
labs listed at the conference SB 2.0, in 2006.  
If the proponent of the label synthetic biology did not belong to the core group of 
American scientists who promoted this discipline along the Synthetic Biology X.0  
conferences (2004, 2006, 2007, 2008, 2011), how are we to understand that this phrase 
eventually came to prevail and acted as a signpost for bringing together research groups into a 
community?  
There is a variety of research programs gathered under the umbrella synthetic biology. 
In her attempt at “piecing together a puzzle”, Ana Deplazes distinguishes five different 
approaches: Bioengineering, aiming at making biological parts, devices, and systems, 
synthetic genomics, aiming at making chassis through DNA synthesis, protocell synthesis, 
unnatural biology, aiming at synthesizing exotic DNA, and in silico biology, aiming at 
designing organisms. (Deplazes, 2009) Bioengineering is only one approach among four 
others, though they receive most attention in the press and in the media. There is a striking 
imbalance between the small emerging community of bioengineers gathered around Drew 
Endy, Jay Keasling, Rob Carlson who took the initiative of the conferences Synthetic Biology 
X.0 and the huge number of research groups of chemists, biochemists, biophysicists, who 
bring their own practices and cultures in the field.5  
For the small group of bioengineers who worked hard to promote synthetic biology as a 
discipline, synthetic biology proceeds from the fusion of two worlds: molecular biology 
which provided access to the building blocks of life and computational technologies 
pioneered by cybernetics. (Carlson, 2010, p. 6) Whilst it is clear that they do not take 
inspiration from chemistry, the parallel with synthetic chemistry is nevertheless acceptable for 
them in so far as it usually comes with two revolutionary claims: synthetic biology will 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5 Among the groups who publish in the five fields mentioned by Desplazes are: Eric Kool's group at Stanford, 
Carlos Bustamante's group at Berkeley, Jack Szostak's group working on protcells at Harvard, David McMillen's 
group at University of Toronto, and Steve Benner’s group or the famous Craig Venter’s group. 
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deeply affect our lives and the world as synthetic chemistry did in the past; and synthetic 
biology will provide safer and cleaner substitutes for chemicals. (Keasling, 2008) In other 
words, the message conveyed by this label could be: Synthetic biology is bound to overtake 
synthetic chemistry.  
 If a consensus could be reached around ‘synthetic biology’ because this phrase served 
the ambitions of all research groups working in the field, does it mean that they have similar 
research agendas, visions and models? As it is nearly impossible to survey the research 
agendas of all groups, the paper will now focus on two extremely contrasted visions of the 
field developed by two specific groups.  
 
2. 2005- Two visions of synthetic biology 
 
Among the most cited papers, two articles published in 2005 promote diverging views 
of synthetic biology inspired by two different models. Drew Endy’s famous paper 
“Foundations for Engineering Biology” seeks to promote foundational technologies inspired 
by computer engineering. (Endy, 2005) By contrast Steve Benner’s and A. Michael Sismour’s 
article “Synthetic Biology” provides a review of the field modelled on chemistry. (Benner, 
Sismour, 2005) Interestingly both Benner and Endy are concerned with disciplining synthetic 
biologists: Benner considers that discipline prevents them from always reaching the 
conclusion that they want to reach? (Benner, 2010) Endy considers that the engineers have to 
follow basic rules. 
Endy’s paper introduces engineering methods into biology. Trained as an engineer in 
Civil and Environmental Engineering, Endy did a PhD in Biochemical Engineering at 
Dartmouth devoted to modelling the behaviour of a virus, bacteriophage T7, attacking E-Coli 
bacterium. (Jha, 2005) As too many parameters were out of control to predict the actual 
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behaviour of the virus, he figured out that an artificial virus with a simplified synthetic 
genome containing only functional genes would lead to a more predictable model. He then 
moved to the Biological Engineering Department at MIT where he worked to make biology 
easier to engineer. Endy seeks to import in biology the methods of engineering. He shares this 
objective with the group of scientists who promoted synthetic biology as a new discipline.  
 Endy derives three methodological rules from engineering: standardization, decoupling 
and abstraction. (Endy, 2005) Standardization presupposes the full description and 
characterization of biological parts. Decoupling is a strategy for simplifying a task by dividing 
it into manageable independent operations. Abstraction consists in dealing with each level of 
complexity separately, regardless of their interactions. Although the last two rules could have 
been taken from Descartes Regulae ad directionem ingenii, they were derived from electronic 
circuits engineering. Drew Endy, as well as Rob Carlson, and Roger Brent, the trio who 
supported the label ‘intentional biology’, took inspiration from both electronic circuits and 
software engineering. Their program rests on the creation of a data base, a collection of well-
characterized biological parts that can be assembled in devices and systems. For Endy, 
decoupling and abstraction are not just rules for the direction of the mind since he 
recommends a strict division of labour between the various tasks. This engineering approach, 
emphasizing standardization, modularization, interoperability, transparency and reliability can 
be viewed as a continuation of “engineering ideal in American culture”. (Rabinow, Bennett, 
2007) 
When Endy moved from MIT to Stanford in 2008 his research program reinforced the 
close connection between biological engineering and computer engineering. Among other 
projects his lab is working on a project of engineering genetically encoded memory systems 
with the view to store information within living cells. Thus engineering is the top priority. As 
Evelyn Fox Keller argues, for Endy “synthetic biology’s role is not in understanding 
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organisms as they have evolved, but possibly (…) in understanding how to remake these 
organisms to better and more efficiently serve our ends as human users”. (Fox Keller, 2009, 
296) 
Whereas Endy’s paper was presented as the dawn of a new era, Benner and Sismour 
reviewed an already existing area of research. For them synthetic biology has been around for 
about 20 years. Benner who has been trained as a chemist performed the first synthesis of a 
gene in 1984 and later used organic synthesis to prepare a chemical system capable of 
Darwinian evolution. Accordingly, he is legitimate in claiming that he initiated synthetic 
biology as a field. For him, synthetic biology is basically an extension of bio-inspired 
chemistry. Based on his experience as a chemist, his group has used organic synthesis 
methods to create artificial molecules capable of behaving like biological entities, typically 
enzymes. Benner’s main argument is that synthesis complements analysis. While analytical 
results will never suffice to overthrow a theory, synthesis alone is powerful enough to bring 
about paradigmatic changes. In his view, synthesis is first and foremost a tool for making 
discoveries. His model is Robert Woodward’s synthesis of Vitamin B12 in the 1950s, which 
was like “sending a man on the moon”. The synthetic route was a long multi-step process, 
which provided not only a useful molecule but above all a “better understanding of chemical 
bonding”. Similarly in synthetic biology the failed efforts to synthesize non-ionic DNA 
backbones provided a better understanding of the significant role of repeating charges in the 
functions of DNA. The emphasis on the cognitive role of synthesis does not hamper its 
practical utility. The paper proudly mentions that the synthesis of artificial DNA led to 
branched DNA diagnostic assays developed by the industrial chemical manufacturer Chiron 
and Bayer diagnostics. 
In their review of synthetic biology, Benner and Sismour distinguished two trends: in 
addition to the use of chemical synthesis to reproduce emergent behaviours, they point to 
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another research program seeking to assemble interchangeable biological parts into systems. 
This could be a recognition of Endy’s modular approach to synthetic biology. In fact this 
trend is illustrated by biomimetic chemistry in protein engineering, aimed at reproducing 
isolated behaviours of natural bio-sytems. Its main result according to Benner is a knowledge 
gain, which allowed Benner to go beyond Watson and Crick model of nucleic acids structure. 
The new model emphasizing the role of sugar and phosphate backbone in molecular 
recognition opened up new theoretical perspectives as well as new opportunities for 
personalized medicine. 
 
3. Lessons from history  
 
Disciplinary histories have often been used by scientists as a tool for shaping emerging 
fields. The memory of heroic figures, founding events, and clichés helps building a 
community of practitioners and implicitly conveys goals and values. (Graham, Lepenies, 
Weingart, 1983; Abir-Am, Elliott, 1999) Synthetic biology is no exception. Both disciplinary 
models make extensive use of historical vignettes.  
It seems that the advocates of the computer engineering model found few resources in 
the short history of this discipline as they preferably turn to other engineering disciplines. For 
instance, in his attempt to shape the future of biology as a technology Carlson finds 
inspiration in the history of aeronautics. (Carlson, 2010) He draws at least three 
methodological lessons from it. First, reducing complexity is a necessary condition for 
success. In his view the pioneers of aviation succeeded when they eliminated the mechanisms 
they were unable to understand and reproduce. “No biological engineer will success in 
building a system de novo until most of that complexity is stripped away, leaving only the 
barest essentials”. (Ibid. p. 6) A second key for success was the quantitative approach, with 
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models to be tested. Aviation with aircrafts heavier than air proceeded from knowledge of the 
physics of flight and practical experience with flight was a kind of test of theoretical models. 
(Ibid. p. 7, 21, 40-41) And the third lesson is jointly taught by the history of aviation and 
computers: Innovation comes from outside academic circles and big industrial labs, so garage 
biology should be encouraged. (Ibid. , p. 176) 
The chemical model benefits from more direct parallels with the history of nineteenth 
century synthetic chemistry. For instance, Yeh, and Lim (2007) compared the recent shift 
from molecular biology to synthetic biology to the transition that chemistry underwent in the 
mid-nineteenth century from a science focused on the determination of nature and proportions 
of compounds (through analysis) to a science aimed at synthesising new compounds. The 
latter generated the flourishing industry of fine chemicals that synthetic biology is said to 
overthrow in the near future. Twentieth-century biology is thus reconfigured as an analytic 
(rather than descriptive) science for the purpose of presenting the development of synthetic 
biology as the ineluctable consequence of the analytical phase.6  
Without entering into any detailed historical survey, the paper gives a superficial 
glimpse of the history of nineteenth-century chemistry, relying on a selection of almost 
legendary figures of past chemistry. (Bensaude-Vincent, 2009) In the usual ‘whig’ manner, 
the authors select the episodes that can serve the point they want to make. In this case they 
argue that synthesis is a necessary complement of analysis for the advancement of knowledge. 
“Before the time of Wöhler and Berthelot the understanding of even simple molecules was as 
naïve as our current understanding of complex biosystems” (Yeh and Lim, 2007: 522). The 
paper minimizes the amount of knowledge acquired by twentieth-century biologists in order 
to stress the historical necessity of synthetic biology. “The history of organic chemistry 
suggests that synthesis will be a necessary complement to analysis in order for biologists to 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
6 To systems biology also, chemistry may provide a model as suggested by Pawan K Dhar’s paper (2007) who 
argued that a bio-periodic table using protein fold as the fundamental unit.in biology would allow to compute 
higher-level interactions from component properties.   
	   13	  
truly understand the mechanisms of complex living systems”. (Ibid. : 523) Thus a first benefit 
of the chemical analogy is that it can be used for legitimating projects and investments in 
synthetic biology.  
More lessons could have been inferred from this historical parallel for the benefit of the 
synthetic biology community. In particular, since chemical synthesis has been promoted in the 
nineteenth-century both as a cognitive method and as a source of material goods, since heavy 
investments from industrial companies were coupled with intensive academic research, the 
parallel could be used for legitimating the dual nature of synthetic biology: as a promising 
technology attracting venture capitals or industrial investments and as a cognitive enterprise 
aimed at improving our understanding of life. The parallel could also serve to dismiss the 
potential concerns raised by the entanglement of cognitive and commercial purposes since a 
number of nineteenth-century synthetic chemists coupled an academic career with positions in 
industrial companies.7  
However the dual cognitive-commercial profile of synthetic biology is not a priority for 
the authors, who do not bother about potential conflicts of interest arising between the ethos 
of academic research and industrial interests. They accordingly develop a particular view of 
nineteenth-century chemistry exclusively focussed on the cognitive dimension of synthesis. 
As it emphasizes the limitations of analytical knowledge, the paper claims that nineteenth-
century synthetic chemists did not know the composition and the structure of the substances 
that they synthesized. However disputable this claim might be8, it matters because it conveys 
the view that it is perfectly legitimate to make things without fully understanding what you 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
7 The life of Adoph von Baeyer could serve as an exemplar of the benefits that can be expected from 
intertwining academic and industrial careers. This organic chemist, former student of Kekulé, played a key role 
in industrial chemistry take-off, while conducting a prestigious academic career. A Professor at the University of 
Munich and later at the University of Strasburg, he was awarded the Nobel Prize for Chemistry in 1905. At the 
same time he was working at the corporate laboratory of BASF, where he and his pupils managed to achieve the 
industrial synthesis of indigo after years of research and many patents (see Haber, 1958, Reinhardt, 1996). 
8 For historians of chemistry this claim is highly controvertible. Marcellin Berthelot for instance emphasized that 
through synthesis chemistry had become a predictive science and illustrated its predictive power with Adolphe 
Wurtz’s work on glycols. (Berthelot, 1897, p. 190-192). 
	   14	  
are doing. “A critical lesson here is that a complete understanding of chemical principles was 
not a prerequisite for the emergence of synthetic chemistry. Rather, synthetic and analytical 
approaches developed in parallel and synergized to shape our modern understanding of 
chemistry.” (Ibid.,523) The analogy allows synthetic biologists to explore all kinds of 
combinations without being able to control and predict the outcome, for lack of understanding 
of the principles. In a way, the chemical model gives a moral license to play the sorcerer’s 
apprentice. As explorers of uncontrollable powers, synthetic biologists cannot always be held 
accountable for what they do. 
Although they are obviously more concerned with academic research, the authors 
cannot completely overlook that part of current research efforts in synthetic biology are 
application-driven. “In today’s world, many tend to link synthetic chemistry with the 
production of drugs. Indeed, it was abundantly clear to early chemists that synthetic products 
could improve human health, but their initial efforts actually led to an industrial explosion in 
an unexpected direction.” (Ibid. :523) They nevertheless find in this other face of nineteenth-
century chemistry a new example to claim as much academic freedom as possible. They use 
the episode of William H. Perkin who discovered a synthetic dye (mauve), while he was 
conducting research on quinine, an antimalaria drug, to emphasize the role of unexpected 
results. They also claim that this classical case of serendipity was the starting point of the 
booming synthetic dyestuff industry in the late nineteenth century. Thanks to this simplistic 
raccourci (which overlooks the complexity of the process leading from aniline to alizarin 
dyes and from laboratory discovery to industrial process) Yeh and Lim suggest that 
unexpected results are the rule rather than the exception. Hence a third lesson drawn from the 
history of synthetic chemistry: 
 “Synthetic biologists (and their funding agencies) must move forward with an open 
mind. The progress of synthetic biology cannot be myopically linked to only a few 
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obvious targets; instead, we must be prepared for a variety of potential industrial and 
therapeutic applications, including unexpected ones that we have not yet foreseen.” 
(Ibid.: 524) 
Thus the parallel with synthetic chemistry is meant to secure a large autonomy for 
synthetic biologists.9 Unlike the champions of an engineering view of synthetic biology, the 
chemistry model seeks a better understanding biology through synthesis. Looking back at the 
two simultaneous papers published in 2005 and at the lessons drawn from a historical parallel 
one gets the impression that two independent communities with their own goals, visions and 
ideals are using the same label ‘synthetic biology’ without interfering. Significantly Benner 
has never been invited as a keynote speaker in the annual conferences (most of them 
organized by the biobricks community) until SB 5.0 in June 2011. Are there two different 
synthetic biologies running parallel or do they really share common projects? Should we 
acknowledge the possibility of constructing a discipline on the basis of epistemic pluralism?  
  
4. Alternative models?  
 
Although Endy’s conviction that synthesis can be made easier through a modular 
approach is clearly inspired by electronic circuit engineering, it meets the view of synthesis as 
reverse analysis which comes from chemistry. In this respect it is noticeable that Endy does 
not take literally the computer metaphor for living systems. Unlike cybernetics-inspired 
biologists who claim that any aspect of biology can be examined computationally”, he does 
not advocate a computational program. Whereas many systems biologists could pronounce a 
cybernetic credo “if you can’t compute it, you don’t understand it”, Endy and his disciples 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
9 Yet as Andrew Maynard, a scientific advisor for Synthetic Biology Project at the Woodrow Wilson 
International Center for Scholars pointed out in his comment of Yeh and Lim’s paper, the historical precedent of 
synthetic chemistry could teach synthetic biologists quite different lessons. (Maynard, 2008) The damages and 
hazards due to a number of synthetic chemicals could be used for raising concerns and invite synthetic biologists 
to a more precautionary attitude in order to secure a sustainable development of  synthetic biology. 
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rather believe in Feynman’s credo “what I cannot create, I do not understand”.10 Ironically 
Endy’s strategy from the simple-to-the-complex as exemplified in the sequence from 
biological parts, to devices, and systems could have been inspired by a famous nineteenth 
century synthetic chemist, Marcellin Berthelot. There is a striking analogy between 
Berthelot’s program of gradual synthesis and Endy’s biobricks approach. For Berthelot the 
development of synthetic chemistry would not depend on inspiration or intuition, but requires 
a gradual step by step procedure. (Berthelot, 1897) Starting with the elements carbon and 
hydrogen to synthesize binary compounds – the hydrocarbons - that constitute the backbone 
of all organic assemblies; then synthesizing ternary compounds (alcohols); follow up with the 
synthesis of quaternary compounds through combinations of lower compounds, and so on. 
Similarly Endy advocates a step-by-step approach moving from independent parts, to devices 
and then to systems. The champion of synthetic chemistry and the champion of synthetic 
biology share the conviction that the rational simple-to-complex method of design is the key 
to success.  
Indeed Berthelot never achieved his grandiose programme to synthesize the complex 
compounds found in living organisms from the four elements, carbon, oxygen, hydrogen, and 
nitrogen. Similarly, up to now, Endy and his group have not achieved the synthesis of any 
biological system. The gulf between actual practices and the ideal of rational design creates 
another rapprochement between the chemical model and the computer model. Just as 
synthetic chemists working at the bench make molecules partly by chance, in a manner 
combining logic, tricks, and serendipity, (Hoffmann, 1995) so do synthetic biologists. 
Although synthetic biologists want biology to be rational and elegant, the few devices and 
organisms that have been successfully synthesized were made from pre-existing systems, 
through a lot of tinkering, trials and errors, and iterations. As Maureen O’Malley convincingly 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10	  O’Malley (2009) revisits the meaning of Feynman’s too famous quotation and discusses its relevance for 
synthetic biology.	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argues on the basis of a few examples lots of tinkering and kludging are involved in 
assembling the pieces to make a device  (O’Malley, 2009). In this respect like in many others, 
synthetic biology is close to computer engineering where the term ‘kludge’ (combination of  
klumsy, ugly and dumb) originated.11   
If the chemical model and the computer engineering model inspire similar strategies of 
synthesis, is it because they rely on the same metaphysical assumptions? Indeed the advocates 
of the chemical model consider DNA molecules as a code programming a number of 
operations. Nature is viewed as a source of code rather than as a source of raw materials. In 
other terms for all synthetic biologists, life is information. They also give prominence to 
functions over structure, they all look at the building blocks as functional units performing 
specific operations.12 
From an epistemological perspective they equally share Feynman’s credo that 
knowledge is acquired through creation or synthesis. (Schmidt, 2009) However the computer 
engineering model rests on the ideal: knowing before assembling. For Endy and his 
colleagues synthetic biology should follow engineering methods beginning with specification. 
The design process starts with a detailed description of the explicit requirements of a product. 
In the following stage, engineers attempt to combine existing parts, devices or systems in a 
way that will yield a product meeting those specifications. The parts should be plain clear and 
the assembly process is entirely predictable. It is intentional biology because the object of 
design results from a combination of intention and prediction. While knowing is a 
precondition for making in the engineering view of synthetic biology, it is not necessarily 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
11 Computer engineers use pieces of software (‘patches’,) to fix problems or clear up programs from all sort of 
bugs that hamper or diminish their performances. Bugs are often generated by various layers of language in a 
programme. Just as the genetic programme keeps vestiges  of its evolution, computer programmes are full of 
traces of earlier stages without a source code or which no longer fit in the most recent language. 
12 Their shared concern with functionalities relies on the many different meanings of the term ‘function’. 
Functionalizing most often means implementing useful tasks, sometimes creating chemical bonds and more 
rarely integrating an entity in a larger system to contribute to the emergence of new properties in the system. 
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understanding. As the purpose is not representing life as it is, or how it evolved, knowing 
rather means coming out with a framework of life for our intervention into it.  
By contrast the chemical model being more about gaining a better understanding of life 
through synthesis requires making without fully knowing. If synthesis allows making 
discoveries and paradigm shifts, as Benner argued in his 2005 paper, it is because synthesis is 
much more than a process of reverse analysis confirming analytical results. If the authors 
emphasized that they needed a moral license to combine things without being able to predict 
the result, it is because synthetic chemists know how many detours, skills, tacit knowledge 
and tours de force are involved in the art of synthesis. (Hoffmann, 1995) As chemical 
syntheses rely on inner dynamics of molecules and interactions between them and with their 
environment, they are rather opaque processes. To chemists, Endy’s ideal of interchangeable 
biological parts looks naïve as it makes no allowance for intrinsic interactions between 
dissolved molecules. With the experience of more than a century of molecular design 
chemists know that interoperability is a major challenge.  
 
5. Divergent social practices 
 
Because of their unequal ratios between knowing and making, the two models of 
synthesis do not engage the designer’s responsibility in the same manner. Whereas the 
algorithmic approach to synthesis inspired by engineering requires a blueprint of the process 
to make it predictable, the chemical approach always allows surprise, hazards and 
opportunities to occur. The engineers-designers of biological devices can be held fully 
responsible for their predictable results while the chemists-designers have to go through trials 
and errors and pilot plants before a synthetic process can be safely handled. Material 
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ingredients – whatever they be - have a spontaneous behaviour and need to be tamed though a 
long process of acclimatization and domestication.  
In addition, the two trends have divergent views on ownership and sharing. The 
tradition inherited from chemical and pharmaceutical industries encourages biosynthetic 
chemists to patent their products at each stage of the process and they are in favour of 
proprietary databases. As soon as industrial or medical applications are in view they are made 
for profit. For instance Benner’s career illustrates a clear-cut distinction between profitable 
tools or platforms for pharmaceutical industries and cognitive enterprises. On the profit side, 
he founded biotech start-ups such as EraGen Biosciences and the MasterCatalog of protein 
modules used as a proteomics platform by the Genome Therapeutic Corporation. The non-
profit side is Benner’s research at the Foundation for Applied Molecular Evolution (FAME), a 
centre for innovative research at the crossroad between molecular and planetary sciences in 
search for extraterrestrial life.  
By contrast, synthetic biologists inspired by engineering work seek to secure 
simultaneously the academic and industrial futures of synthetic biology through open source. 
It is not just a variation about precisely where to draw the line on public versus private 
ownership. (Oye, Wellhausen, 2009) There is a disagreement within the US community of 
synthetic biologists about whether or not private property is necessary to spur innovation. Rob 
Carlson challenges the established demarcation line between upstream open academic 
research and downstream private applications. He advocated the combination of academia and 
industry from the beginning: 
“The course of labor in biological technology can be charted by looking at the 
experience of the computer and internet industries. Many start-up companies in Silicon 
Valley have become contract engineering efforts, funded by venture capital, where 
workers sign on with the expectation that the company will be sold within a few years, 
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whereupon they will find a new assignment. The leading edge of the biological 
technology revolution could soon look the same”. (Carlson, 2001)  
Endy, Tom Knight and Randy Rettberg created a data base of biological parts – the 
Registry of Standardized Biological Parts - at MIT and at the same time encouraged young 
people to practice synthetic biology. The collection increases thanks to the students teams 
involved in the annual International Genetically Engineered Machine Competition (iGEM). 
The participants are given biological parts stored in the registry at the beginning of summer 
and they have to combine them for designing a device or a system to be presented at the big 
Jamboree in Cambridge in autumn. They subsequently return the products of their designs to 
the registry.  
“The Registry is based on the principle of "get some, give some". Registry 
users benefit from using the parts and information available from the 
Registry in designing their engineered biological systems. In exchange, the 
expectation is that Registry users will, in turn, contribute back information 
and data on existing parts and new parts that they make to grow and 
improve this community resource”. (http://partsregistry.org/MainPage)  
The “get some, give some” principle, taken from the open source movement in software 
engineering is the basis of the creation of the Biobricks Foundation, a not-for-profit 
organization aimed at promoting data sharing, open technical standards, and the free 
availability of the biological parts. Thus as Stephen Hilgartner emphasizes, the Biobricks 
Group tries to promote a new regime of sociability through biology. The regime of openness 
subverts the current practice of patenting every step, it also challenges the divide between 
amateurs and experts, its ambition is to generate a new social order  (Hilgartner, 2010, 3) The 
coupling of data production and social reorganization is a major component of Carlson’s 
programme of intentional biology. As early as 2001 in a paper entitled “Open source and its 
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impact on industry” he claimed that bio-engineering would become so cheap and easy that it 
would be accessible to amateurs, and since 2001 he has actively encouraged garage biology. 
The promotion of amateur science is even encouraged by some universities: Johns Hopkins 
University shares the conviction that synthetic biology is so easy that it is accessible to 
beginners with no prerequisite, and no disciplinary background. It offers an interdisciplinary 
Build-a-genome Course in the undergraduate curriculum, which suggests that medical 
students could get rid of the biological heritage. (Cooper EM, et al., 2012) 
The project of subverting the hierarchy between experts and laypersons is not necessarily 
inspired by democratic ideal. As Hilgartner argues, the discourse of openness in synthetic 
biology has no clear political agenda:  
“BioBrick regime, while potentially well-suited to create a significant community 
resource of available parts, looks like a relatively conventional IP-minimalist regime. 
As such, it does little to address increasingly pressing questions about how property 
rights in emerging technology impinge on democratic decision making. » (Hilgartner, 
2010, p. 19). 
In contrast to European synthetic biologists who are aware of the public resistance to 
GMO crops, Endy and Carlson are not open to public debates or stakeholders meetings. They 
are not concerned with all the discussions and experiments going for promoting democracy in 
technology. (Callon et al. 2001, Feenberg, 2010). They are more in favour of a self-regulation 
of the scientific community about issues of safety and security. The series of Syn. Bio 
conferences and the Synthetic Biology Research Center are working in this direction. While 
participatory democracy is not even envisaged, government regulations are strongly criticized. 
In discussing issues of security and safety, Carlson develops the example of illegal drugs to 
argue that all regulations are leaky, not only inefficient but even counterproductive: 
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“Regulation is therefore causing a shift from distributed, domestic production to foreign 
centralized, criminal organizations”. (Carlson, 2010, p. 125) 
   Moreover, despite the subversion of academic hierarchies, the regime of openness is 
not really engaged in a social revolution. The main objective is cost reduction for the 
industrial take off of synthetic organisms. The history of work organisation in capitalism has 
taught us that cost reduction goes hand in hand with the simplification of operations, and a 
subsequent deskilling of workers which allows their replacement by machines and a cost 
reduction for maximum profit. Although the discourses about the iGEM competition are all 
about creativity, fun and excitement, the students provide a cheap way to fill the library of 
biobricks and to foster the process of cost reduction. Indeed students are not robots, but the 
replacement of technicians by automata has been very quick in DNA sequencing and the 
subsequent cost reduction over the past decade has been spectacular: from $5000 for one 
million of bases in 2001 to $0.08 in 2011.  
Carlson’s future prospect of open source bioengineering is inspired by a rejection of the 
current patents held by big pharmaceutical companies, which slow down innovation. 
However Carlson’s criticism of biocapitalism does not mean that he wants to promote an 
alternative to capitalism. (Rajan, 2006) Far from trying to step away from market economy 
Carlson advocates an open, free, deregulated market. He is convinced that the market push 
will drive the future of synthetic biology: “Where there is a market there will always be 
attempts to supply it, even when the product is both legally and culturally frowned upon”. 
(Carlson, 2010, p. 126) Carlson consequently advocates a deregulated and open innovation 
based of creative entrepreneurs and small firms rather that big pharmaceutical companies: 
“The development of fundamentally new technology in a market economy requires and 
explicitly depends upon the participation of small firms and entrepreneurs.” (Ibid. p. 134) 
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The assumption underlying Carlson’s vision and the Biobricks project is that easiness 
and openness will enlarge the number of users and consequently bring added value to 
synthetic biology. This credo drove the spectacular diffusion of computer technologies under 
the auspices of the so-called Moore’s law predicting the rate of increase of computing power 
and of costs decline. Carlson formulated a similar projection for synthetic biology (known as 
Carlson’s curve) predicting that the sequencing of a human genome for $1000 in 2020. 
Computer industry provides the roadmap for synthetic biology with an exponential rate of 
development and a flourishing industrial future in a deregulated market economy. Similarly 
the source of value in open biology will be the electronic information that specifies the 
biological function. “When it eventually becomes possible to synthesize DNA at will for 
minimal cost ant to run the ‘program’ in an orgnism at one’s choice, there may well be no 
market for the object defined by the program. In that world the value of DNA truly becomes 
its informational content. The only money that would exchange hands in transaction would be 
to pay for the DNA synthesizer and for reagents and raw materials to run the synthesizer” 
(Carlson, 2010, p. 217)  
 Carlson’s strong advocacy of open-source and deregulated bioeconomy has a 
paradoxical and certainly unintentional consequence. In his effort to secure the most 
promising future for synthetic biology, he provides weapons to its critics and opponents. In 
his book Biology is Technology, one can find the most severe critical analysis of the state of 
the art in synthetic biology. From an economic perspective synthetic biology as it is now is 
not sustainable. In particular, Carlson undermines the commercial future of the most 
celebrated prowess. Keasling’s work on malaria through ad hoc engineering and tinkering is 
too expensive too be realistic from a commercial production. (Ibid. p. 100-101) Just for 
Venter’s experimental assembly published in 2008, $ 2 million have been spent and much 
more is needed for a second step and hundred times more for scaling up (Ibid. p. 104-105). 
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Carlson also unwillingly casts doubts on the economic potentials of the Registry of Standard 
Biobricks when he confesses that most biological parts designed by students in iGEM 
comptetitions do not work, that only a few standard parts are well characterized. (Ibid. p. 96) 
He emphasizes such defects as proofs that synthetic biology is still in its infancy and that it 
needs to mature in a near future. 
 
Conclusion 
 
Synthetic biology provides an interesting case study for understanding the complex 
process of discipline-building, because of the paradoxes in its early development, which may 
impact on its future. Choice of a disciplinary profile despite the multidisciplinary practices, 
choice of a label ‘synthetic biology’ which does not mirror the programme of those who work 
hard at the promotion of the new discipline. It is important to stress that synthetic biology in 
the USA is not a monolithic block.  
The contrast between the two disciplinary models presented in this paper is just an 
example of the epistemic pluralism, which dominates the field. Different research groups have 
different agendas, different relations to the past, and different visions of the future. Along the 
lines of synthetic chemistry, the new discipline looks like the continuation and completion of 
twentieth-century biology. It opens an era of plenty both for the advancement of knowledge 
and for practical applications. It is not disruptive as it legitimates the pursuit of academic 
research together with industrial enterprises, and commercial profits. By contrast the 
engineering model supports claims of a radical break in the biological research tradition. In 
encouraging amateur practice and openness it seems to disrupt the academic regime of 
knowledge production as well as the regime of intellectual property that covers 
biotechnological products. It develops a new mode of knowledge sociability and economy.   
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If epistemic pluralism is a major feature of emerging fields like synthetic biology, how 
are we to interpret it? Is it a temporary state of a discipline in its infancy prior to the 
implementation of a dominant paradigm? In this case the two disciplinary models of synthetic 
biology would be competing for primacy in a kind of Darwinian selection. Or should we 
consider the coexistence of various epistemic cultures a typical feature of “normal science” in 
a time when research is driven by instruments, by economic interests and science policy? In 
this case epistemic pluralism would be the hallmark of a post-academic regime of knowledge 
production. 
Although Carlson insists that synthetic biology is still in its infancy there is no hint of 
any rivalry that would suggest a Darwinian competition. There are certainly tensions between 
the groups of practitioners and maybe some scepticism about the research agendas of rival 
groups, but to my knowledge there are no attempts at disqualifying them. The choice of a 
disciplinary profile did not raise any concern for constructing a coherent framework out of the 
diversity of epistemic cultures. Pluralism is not perceived as threatening the future of the 
discipline. On the one hand, the discrepancy between the two models here described is 
qualified because they are just two extremes in a wide spectrum of research agendas, as 
mentioned in the introduction. On the other hand, the potential conflicts between the 
proponents of the two models have been neutralized for at least two reasons. 
First, they converge in the belief that despite the current obstacles and bottlenecks, in 
the future synthetic biology will bring about solutions to all current issues, from the origin of 
life, extra-terrestrial life, to the production of renewable energy and cheap medicine. This 
technological optimism reminiscent of the scientistic credo of nineteenth-century chemists, 
contrasts with moderate expectations in public opinion, who seem to favour a moratorium on 
synthetic biology products. (http://www.genengnews.com/gen-news-highlights/gen-poll-
majority-favors-moratorium-on-synthetic-bio-products/81246614/)  
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Second, applying open source ideals to biology and encouraging amateur practices has 
not so far disrupted the course of professional research and the fierce competition between 
industrial countries. As long as sophisticated and expensive technical platforms equipped with 
up-to-date instruments are needed for achieving reliable syntheses, garage biology will remain 
a hobby for young creative people (or for eccentric millionaires). Noble discourses about 
freedom, creativity and the annual festive jamborees in Cambridge are far from sufficient to 
initiate a democratization process. Despite the discourses and the promises, the discipline 
grows in the USA with no democratic basis and no concern for democratization. 
Whether the regime of openness initiated by the Biobricks Foundation can prevent the 
kind of monopolies that prevailed in former biotechnology, such as GMO crops, remains an 
open question. Will the champions of openness stop the race for patents? Will they secure the 
free availability of all products, and not-for-profit initiatives? Or alternatively will all 
synthetic biologists follow on the path of Craig Venter’s mad pursuit of spectacular synthetic 
tours de force, and patent applications covering general aspects in order to conquer a position 
of monopoly? Or will the community split up with a fraction continuing the patent regime that 
presided over the development of industrial chemistry since the nineteenth-century and 
another fraction taking advantage of the emergence of this new technology to create a new 
social order? The future of synthetic biology is still open, and may not be entirely in the hands 
of synthetic biologists. It depends partly on industrial investments, on science policy, not only 
in the United States but in Asia and Europe as well. However is likely that epistemic 
pluralism will continue to rule this discipline for a while and that synthetic biology will never 
be a replica of synthetic chemistry, never become a “discipline as we know it”. 
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